Document is current
Any future updates will be listed below
-
Authors
Lasorella, Anna http://orcid.org/0000-0002-1839-5421
Iavarone, Antonio http://orcid.org/0000-0002-0683-4634
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA101644, U54CA193313, R01CA131126, R01CA239721, U54CA193313, R01CA178546, R01CA179044, R01CA190891, R01CA239698)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Chemotherapy Foundation (no number)
- License Information
-
More Information
Article History
Received: 3 March 2021
Revised: 8 March 2021
Accepted: 11 March 2021
First Online: 25 March 2021
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: A.L. and A.I. are listed as inventors on patent applications filed by Columbia University related to the diagnostic and therapeutic applications of the functional classification described here.
: This work was supported by NIH R01CA101644, U54CA193313, R01CA131126 and R01CA239721 to A.L.; R01CA178546, U54CA193313, R01CA179044, R01CA190891, R01CA239698, and The Chemotherapy Foundation’s grant to A.I.
